Pulmonary sarcoidosis is the most common interstitial lung disease (ILD), especially in
middle-aged patients. 1, 2 Because of its heterogeneous onset and manifestations, the initial …

The aim of this manuscript is to provide a comprehensive review of the etiology,
measurement, and treatment of common pulmonary symptoms associated with sarcoidosis …

Sarcoidosis is a systemic granulomatous disease with heterogenous clinical manifestations.
Here we review the diagnosis of sarcoidosis and propose a clinically feasible diagnostic …

Sarcoidosis is a multisystem disease for which diagnosis relies on the integration of clinical,
radiologic, laboratory, and pathologic information. Assessment of clinical features is an …

A variety of phenotypic categorisations have been developed for sarcoidosis. Phenotyping
has been used for genetics studies and to guide treatment selection. The authors …

Rationale: Sarcoidosis is known as a disease with high heterogeneity in clinical severity and
inflammatory activity. On the basis of radiologic criteria, John Guyette Scadding developed a …

Sarcoidosis is a systemic disease of unknown cause with very diverse presentation,
outcome, severity and need for treatments. While some presentations may be very typical …

The widespread perception that sarcoidosis is essentially a benign disease has
undoubtedly contributed to a lack of investment in sarcoidosis-related public health and …

The natural course of sarcoidosis is highly variable. It is a disease that may never lead to
symptoms or functional impairment. However, sarcoidosis may cause distressing symptoms …

Sarcoidosis is a multi-systemic inflammatory disorder of unknown origin characterized by the
formation of noncaseating granulomas with common involvement of the lungs and …